The company’s largest center for medical device applications, serving the entire Asian market
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
Scores highest PAT of Rs. 118 crore in FY25
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
The European regulator will conduct a re-inspection of the facility to verify the compliance
Subscribe To Our Newsletter & Stay Updated